Recently Viewed

News Announcement

Aurobindo Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011

28-Jun-2019 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for K Nityananda Reddy

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.